Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tixagevimab (AZD8895) is a human monoclonal antibody that targets the receptor binding domain (RBD) of SARS-CoV-2, neutralizing the virus by preventing the S-glycoprotein from binding to its receptor through attachment to the RBD and the S-glycoprotein ectodomain [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder |
Description | Tixagevimab (AZD8895) is a human monoclonal antibody that targets the receptor binding domain (RBD) of SARS-CoV-2, neutralizing the virus by preventing the S-glycoprotein from binding to its receptor through attachment to the RBD and the S-glycoprotein ectodomain [1]. |
Cas No. | 2420564-02-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.